D-0510-2026 Class II Ongoing
FDA drug recall D-0510-2026 was initiated by Apotex Corp. on Apr 8, 2026 and is designated Class II. Reason for recall: Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners. The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 22, 2026
- Initiation Date
- Apr 8, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0
Reason for recall
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Distribution pattern
U.S.A. Nationwide
Code information
Lot #: VM4231, Exp 06/30/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0510-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026